A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven ...
Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited to those researching opioid pharmacology,” said Rolling Stone. Nitazene’s ...
America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — ...
Opioids are still widely prescribed, but have limited effectiveness and are associated with serious harms. De-prescribing ...
This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.
By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Opioids. Financial supporters for this research include NIH National Institute on Drug Abuse, Office ...
ALot.com on MSN
Medicines That Could Increase Your Risk of Dementia
The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...
Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback